CARLSBAD, Calif., Nov. 29, 2017 /PRNewswire/ -- Natural
Alternatives International, Inc. ("NAI") (NASDAQ:NAII), a leading
formulator, manufacturer and marketer of customized nutritional
supplements, announced today that on November 22, 2017, the U.S. Patent and Trademark
Office issued a Notice of Allowance for NAI's patent application
entitled "Compositions and Methods for the Sustained Release of
Beta-Alanine." The newly allowed application becomes part of
NAI's global patent estate covering its SR CarnoSyn®
beta-alanine product.
Mark A. LeDoux, NAI's CEO and
Chairman of the Board, said, "This new patent is another integral
component of NAI's SR CarnoSyn® beta-alanine patent
portfolio. These claims are an important part of our global
strategy for providing performance increases well beyond those
achievable through normal diets." NAI's allowed application
contains claims directed to human and animal dietary supplements
containing sustained release beta-alanine in formulations that
permit the release of beta-alanine over time. The unique
sustained release provides a steady, manageable rate of release
following consumption, which helps the body's uptake of
beta-alanine to form carnosine via a steady presence over time of
beta-alanine in the blood system.
NAI, headquartered in Carlsbad,
California, is a leading formulator, manufacturer and
marketer of nutritional supplements and provides strategic
partnering services to its customers. NAI's comprehensive
partnership approach offers a wide range of innovative nutritional
products and services to NAI's clients including: scientific
research, clinical studies, proprietary ingredients,
customer-specific nutritional product formulation, product testing
and evaluation, marketing management and support, packaging and
delivery system design, regulatory review and international product
registration assistance. For more information about NAI, please see
its website at http://www.nai-online.com.
This press release contains forward-looking statements within
the meaning of applicable securities laws that are not historical
facts and information. These statements represent our intentions,
expectations and beliefs concerning future events, including, among
other things, our expectations and beliefs with respect to our
future financial and operating results, the outcome of pending
litigation, the continued validity of our patents, and our ability
to successfully develop, license and enforce our intellectual
property rights. We wish to caution readers these statements
involve risks and uncertainties that could cause actual results and
outcomes for future periods to differ materially from any
forward-looking statement or views expressed herein. NAI's
financial performance and the forward-looking statements contained
herein are further qualified by other risks including those set
forth from time to time in the documents filed by us with the
Securities and Exchange Commission, including our most recent
Annual Report on Form 10-K and Quarterly Report on Form 10-Q.
CONTACT – Kenneth Wolf,
President, Natural Alternatives International, Inc., at
760-736-7700 or investor@nai-online.com.
View original
content:http://www.prnewswire.com/news-releases/natural-alternatives-international-inc-announces-allowance-of-new-us-sustained-release-beta-alanine-patent-application-300564045.html
SOURCE Natural Alternatives International, Inc.